Agree. I wouldn't be surprised he waits at all to
Post# of 72440
Posted On: 05/29/2016 3:46:59 PM
Agree. I wouldn't be surprised he waits at all too.
Aspire funding can easily take care of the costs. Testing is quick then partnership which can fund multiple tests of B and K. We may be looking at a few more months.
The BK proposal is also possible where there is a significant amount upfront to do testing then benchmarks for P success could be accepted short term. Can provide funds to initiate B p3 too. We'll see. With all the new drug candidates Menon is coming up with, he'll figure out a way to make it happen and I'm sure he will.
It's going to be fascinating to watch.
Aspire funding can easily take care of the costs. Testing is quick then partnership which can fund multiple tests of B and K. We may be looking at a few more months.
The BK proposal is also possible where there is a significant amount upfront to do testing then benchmarks for P success could be accepted short term. Can provide funds to initiate B p3 too. We'll see. With all the new drug candidates Menon is coming up with, he'll figure out a way to make it happen and I'm sure he will.
It's going to be fascinating to watch.
(0)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼